Jose Emilio Peraza, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 252 Broad St, Claremont, NH 03743 Phone: 603-542-6455 Fax: 603-543-0736 |
Dr. Daniel Michael Peraza, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 252 Broad St, Claremont, NH 03743 Phone: 603-542-6455 |
News Archive
How can people who are dependent on prescription opioids reduce their cravings? Learn to enjoy other aspects of their lives.
America's emerging "fat war" threatens to pit a shrinking population of trim Americans against an expanding population of heavy Americans in raging policy debates over "fat taxes" and "fat bans." These "fat policies" would be designed to constrain what people eat and drink - and theoretically crimp the growth in Americans' waistlines and in the country's healthcare costs.
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth of liver tissue in patients who have had parts of their liver removed surgically.
Isis Pharmaceuticals, Inc. announced today that it has earned a $1 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
› Verified 6 days ago